Ackermann Michael 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:45 pm Sale | 2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Ackermann Michael | 1,261,666 6.100% | -205,354 (-14.00%) | Filing |
| 2021-02-12 5:19 pm Purchase | 2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Ackermann Michael | 1,467,020 7.070% | 1,467,020 (New Position) | Filing |